# A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

> **NCT00174785** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 4628 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DRUG:** dronedarone (SR33589)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00174785
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 4628 (ACTUAL)
- **Last updated:** 2010-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174785, "A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00174785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*